chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got the shingles shot and later got shingles/suspected vaccination failure; I got the shingles shot and later got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The age group was not reported but it was selected as an adult as per vaccine indication. The patient got the Shingles and later experienced shingles. The physician did not ask patient whether had chicken pox. The physician said the patient should not get the shot if he or she never had chicken pox. The patient was not happy to say the least. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, event onset time and laboratory confirmation for shingles were unknown at the time of reporting.
Swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen lymph nodes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes). At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.  Very limited information regarding this event/s has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
On 1/15/21, patient developed onset of raised, circular, multiforme rash to bilateral hands involving palms and extended to wrist area. Very itchy, burning, painful with swollen fingers. Seen in my office on 1/18/21. Has improved slightly with Benadryl x 1. No other associated symptoms. No new medications or exposures. Dx of urticarial multiforme vs erythema multiforme.
Approximately 2.5 hours after the injection, a headache developed. I took ibuprofen 400 mg to mitigate the pain. Headache went away after about 30 minutes. Every day the headaches come and go. On October 16, 2021, I spoke with a doctor. He recommended I see my primary care physician. The next day (October 17, 2021), following my annual physical, the headache returned without abating. On Monday, October 18, 2021, I still had the headache from the previous day.  I saw my primary care doctor. It was recommended I try Tylenol 1000mg and the neurology department would be contacted. The following day, I found Tylenol did nothing for my headache so I tried of ibuprofen 600mg. Within an hour, the headache was gone for the day. But return, usually a couple of times every day, coming and going.
patient came in for2nd  covid vaccine, which happen to be his 3rd vaccine. looking to check that he received the first dose 4/23/2021 and what was supposed to be the second dose 5/21/2021. Patient had already had a dose 2/19/2021 that didn't populate into the system when checking.
fever (100 Fahrenheit); chills; sore arm; head ache; fatigue; Vaginal bleeding; This is a spontaneous report from a contactable consumer (patient). A 53-year-old female patient received her second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729), via an unspecified route of administration, administered in left arm on 09Apr2021 03:45 (at the age of 53-years-old) as single dose for COVID-19 immunisation. The patient took the first dose of BNT162b2 (lot number ER2613) on 19Mar2021 at 05:45 PM, administered in left arm. Medical history included kidney stones, over weight, vaginal birth of three live children, tubal ligation, gestational diabetes and menopause. Patient had also allergy to cefzil. Concomitant medication included diphenhydramine hydrochloride (BENADRYL). The patient reported that she woke up at 08:00 on 10Apr2021 and at 08:30 she had sore arm, headache, fatigue, bleeding and chills recovered after rest. At 15:00 she had fever 100 Fahrenheit. Chills, fatigue and headache lasted until 20:00 dosed with acetaminophen and Ibuprofen. On 11Apr2021 at 08:00 bleeding continued. Patient stated that she has started menopause and she had only spotted during cycles, no significant bleeding in 6 months . This bleeding was significantly heavier. The events resulted in Doctor or other healthcare professional office/clinic visit. Vaginal bleeding was not resolved, the outcome of fever was unknown and the other events were resolved.
No adverse event; Patient received expired Monovalent 2nd primary shot of Moderna COVID-19 vaccine on14-MAR-2023 (Lot# 074B22A & Expiration Date: 11-MAR-2023); This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired Monovalent 2nd primary shot of Moderna COVID-19 vaccine on14-MAR-2023 (Lot# 074B22A & Expiration Date: 11-MAR-2023)) and NO ADVERSE EVENT (No adverse event) in a 24-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 074B22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Mar-2023, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 14-Mar-2023,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired Monovalent 2nd primary shot of Moderna COVID-19 vaccine on14-MAR-2023 (Lot# 074B22A & Expiration Date: 11-MAR-2023)). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired Monovalent 2nd primary shot of Moderna COVID-19 vaccine on14-MAR-2023 (Lot# 074B22A & Expiration Date: 11-MAR-2023)) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received expired Monovalent 2nd primary shot of Moderna COVID-19 vaccine on14-MAR-2023 (Lot# 074B22A & Expiration Date: 11-MAR-2023)).    Patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine was unknown. Concomitant medication details not reported by the reporter. NDC number was reported as 80777027310. Treatment details was not reported by the reporter.
Woke up to help my daughter pee and experienced Vertigo, extreme dizziness unable to stand without feeling like going to fall over.   Had help from my husband and drank water, vertigo subsided went back to bed and then was fine
Face partially went numb on left side for about 20 minutes about 10-15 minutes after injection. Numbness then went away.
Upper respiratory symptoms (cough, nasal congestion, rhinorrhea) for 3 weeks
Fever, diarrhea,  chills,  sweats, nausea,  aches,  headache,  tiredness,  shortness of breath
slight headache, fuzziness and heaviness afterward; slight headache, fuzziness and heaviness afterward; slight headache, fuzziness and heaviness afterward; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection), administration date 03Mar2021 (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1), administration date: 10Feb2021, for Covid-19 Immunisation, reaction(s): "heaviness in the forehead; couldn't even consider it a headache". The following information was reported: HEADACHE (non-serious), FEELING ABNORMAL (non-serious), HEAD DISCOMFORT (non-serious) all with onset 2021, outcome "unknown" and all described as "slight headache, fuzziness and heaviness afterward". Additional information: Patient's age was "85" (unit not specified). The events went away then came back a few days later. The patient was asking if it was normal to have a headache, go away and come back.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Seconds after shot he said he was dizzy, then 10-15 seconds later passed out. He was sitting, 911 was called. Patient woke up 15-30 seconds later and was fine. He laid on the floor until ambulance came. He was checked over, signed refusal paper from paramedic and walked out. His wife was in room the whole time. When asked if this happened before he said yes but was years ago. Spoke to wife next day and she said he was fine, no problems
This spontaneous report as received from a other health professional refers to a 5 year old patient.    On 25-JUL-2017, the patient was vaccinated with a dose of M-M-R II and VARIVAX and on 04-AUG-2017, the patient was vaccinated with a dose of PROQUAD lot # M042500 for prophylaxis (inappropriate schedule of drug administration). Concomitant therapies included sterile diluent (MERCK STERILE DILUENT). No adverse effect reported.
Bumpy, dry, itchy, red rash at the site of the injection in the left arm
Information has been received from a certified medical assistant (CMA) referring to an unknown number of patients of unknown age and gender. The patient's medical history and concurrent condition were not reported. The medical assistant reported that 5 doses of improperly stored ROTATEQ (strength, dose and lot # unknown) were administered to patients of unspecified days. Concomitant medication was not reported. No adverse effects were reported. Additional information has been requested.
Started with fever, chills, upset stomach, headache, nausea for a couple days. Over the next week increased severity of earache, headache, and runny nose.  Developed rash on forehead, swollen right eye with pain and loss of vision. Symptoms consistent with shingles.
got very, very sick; Initial information was received on 15-Nov-2020 regarding an unsolicited valid non-serious case from a non-health care professional/consumer via social media.   This case is linked to case 2020SA324592 (same reporter).  This case involves a patient of unknown age who got very, very sick (illness), while patient was treated with influenza vaccine.  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was not reported.  On an unknown date, the patient received influenza vaccine [lot number: unknown and expiration date: unknown] at an unknown dose via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, patient got very, very sick (illness).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the events was unknown.  There will be no information available regarding batch number in this case.
suspected vaccination failure / shingles vaccine in August Today I have shingles; shingles vaccine in August Today I have shingles on my head and face; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In AUG-2022, the patient received Shingles vaccine. On 31-OCT-2022, between 2 and 3 months after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: suspected vaccination failure/shingles vaccine in August Today I have shingles) (serious criteria GSK medically significant) and shingles (Verbatim: shingles vaccine in August Today I have shingles on my head and face). The outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK receipt date: 31-Mar-2023 The case was received from the patient via interactive digital media. On the day of reporting, the patient had shingles on his or her head and face. The patient stated that what the hell. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Fever up to 100.8, full body muscle aches, headache,  fatigue, anorexia, injection site soreness
As per wife's account, patient died approximately 9 days after receiving vaccine on 4/21 of massive, unknown (suspected cardiac) event. Wife explained that patient was diagnosed with Wolff-Parkinson-White (WPW) syndrome prior to being vaccinated. PCP unaware of diagnosis, and patient did not disclose that on vaccine consent form. Patient reported to his wife that he was feeling unwell after receiving vaccine including unable to move legs well. Patient later diagnosed with thrush and supposedly treated by physician. Patient did not discuss concerns regarding vaccine or WPW with physician.  Patient called his wife the day of death and asked her to bring him to the doctor the following day. Wife reported that patient experienced seizures but not concerned as it was similar to childhood seizure. Wife was done at work and drove home after phone call, arriving at house approximately 10-15 minutes after call. Patient supposedly dead when wife arrived. Wife performed CPR for ~15 minutes until EMS arrived, and EMS attempted for another 40 minutes for any electrical activity. Wife declined full autopsy from ME, suspecting that it was massive MI or clot. Wife and patient unaware that WCW could place patient at risk of clots and wondering if the vaccine was partially responsible.
pt recv vax 25APR98 & 29APR98 pt devel a rash & fever of 101;the reporting MD felt that this exp was r/t vax;
I had ocular respiratory syndrome within two to three hours of receiving the vaccine. Both is my eyes reddened and had mild conjunctivitis. I had a deep chest cough and severe exhaustion.  Of course, my arm and neck are still sore.
Pain and persistent tingling throughout arm and hand after first and second dose of vaccine. The tingling in my left arm and hand persisted after the first dose, and increased after the second dose. The tingling in my arm has persisted for 4 weeks now. The tingling has not inhibited my normal activities. Even though I had the second dose in my right arm, the pain and tingling was in my left arm where I had the first dose, and first observed the persistent tingling.
Tested COVID-19 positive after receiving the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested COVID-19 positive after receiving the vaccine) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included No adverse event (No medical history reported.).    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced COVID-19 (Tested COVID-19 positive after receiving the vaccine). At the time of the report, COVID-19 (Tested COVID-19 positive after receiving the vaccine) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, COVID-19: positive positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant or treatment medications reported.
Painful; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: Painful). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.   It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 09-JUL-2023 This case was reported by a patient via interactive digital media. The patient was given the shingles vaccine and it was really painful, he/she imagined that the disease was much, much worse.
Generalized intense itching; Hives all over; Initial information was received on 01-Apr-2020 regarding an unsolicited valid non-serious case received from a consumer/non-healthcare professional.  This case involves a 56 years old female patient who experienced generalized intense itching (pruritus) and hives all over (urticaria), while she received vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  Medical history, past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included INSULIN GLARGINE, LIXISENATIDE (SOLIQUA), INSULIN ASPART (NOVOLOG) and INSULIN DETEMIR (LEVEMIR) for an unknown indication.  On 26-Mar-2020, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number not reported) via unknown route in unknown administration site for prophylactic vaccination.  On 27-Mar-2020, the patient developed a non-serious generalized intense itching (pruritus) and hives all over (urticaria) one day following the administration of INFLUENZA QUADRIVAL A-B VACCINE.  No laboratory data was reported.  Final diagnosis was pruritus and urticaria.   The patient was treated with PREDNISONE (PREDNISONE) and CETIRIZINE HYDROCHLORIDE (ZYRTEK) for pruritus and urticaria.  The patient not recovered from the events of pruritus and urticaria.  There will be no information available on the batch number for this case.
Soreness developed on my right side in the evening on Saturday, May 22nd, approximately one week after receiving the second dose of the COVID vaccine. The next day on Sunday, May 23rd, I noticed the rash where the soreness was on the right side. A day or two later, a rash appeared on my back on the right side. I called the doctor on Monday, May 24th, received a video conference appointment and received a prescription for Valtrex on Monday, May 24th, which I started on that day.  I was on this for 5 days. My doctor examined me on June 4th an confirmed that it was shingles.   My 80 year old mother with whom I live had shingles two weeks before I experienced my first symptoms. She got sick  2 weeks after her first Pfizer dose. About 2 weeks after she got sick, she then developed shingles. She had shingles a couple of years before.
On the evening of the injection, I experienced severe body aches all over (arms, legs, feet) so bad that I could not sleep.  The pain was similar to flu aches, but worse than I have ever experienced, and was like my body was on fire, and all my nerve endings responding. The pain continued through the second night. Was worse at night then than at daytime. I did not take any over the counter medications for the pain the first two nights because I had been advised that taken ibuprofen or other could interfere with the effectiveness of the vaccine. By the third Night, I could not stand it anymore and took an ADvil PM and was able to sleep through the night.  The same pains have continued to the present, with some additional adverse conditions being experienced during the ensuing 37 days since the injection.  On or about the 3rd day, I began experiencing very sharp, intermittent pains in my lower back near left hip.  These pains were sporadic over the next couple of days but eventually went away, only to be replaced by aching pains that began in my buttocks and moved down my legs to feet. These pains are still with me, day and night, and I am taking Advil to try to control them. They are worse when I am standing and also horrible at night.  I am finding it difficult to go about my daily tasks and activities. Other adverse conditions have continued to occur since the vaccination. I experienced several severe unexplained headaches in the week after the injection. In the week after the injection, I also experienced a very sore and stiff neck, so that it was hard to even look to the right or left.  The stiff  neck lasted for several days.(The stiff neck has since went away, and I have not the headaches anymore) But now my arms are experiencing tingling up and down from shoulder to fingertips.  This began sporadically a couple of days after the vaccine, but now is increasing in intensity and frequency. I am also experiencing severe ringing in my ear for the last week or so, or at least, that is when I have become aware of it.  I am really worried about all these symptoms/conditions that began occurring shortly after the vaccination, and am trying to find out what's going on.
Blotchy white/red area with swelling developed at injection site on day 9 after injection with mild itching. Spot is warm to touch. Can provide pictures
Parent states student with body aches and congestion the next day after receiving flu vaccination. Parent kept student home for 1 day gave TYLENOL for body aches and topical "VICKS" for congestion. Improved by day 3.
Cold like symptoms; Cough; Stuffy nose; Cold; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient that,   A female patient of an unspecified age received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 25Apr2021 as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that the received the first dose of vaccine on 25Apr2021 with her husband and on an unknown date she developed cold or cold like symptoms, cough and stuffy nose. She went to her doctor because she thought she had cold like symptoms, on an unspecified date. The doctor did a COVID test which came negative. She was asked to wait before getting the second dose. The outcome for the events was unknown.  No follow-up attempts are possible. information about lot/batch number cannot be obtained.
Patient reported about  several hours after the receiving the vaccine that her left eye was very swollen and that she felt it had a film over it